Kaye Scholer has landed a spot on Law360’s inaugural list of Litigation Powerhouses after winning some of the most noteworthy cases of the past year.
Law360 further recognized Kaye Scholer by listing it among the top five “relatively small but fearsome law firms” that have won “some of the biggest cases over the past year.” These firms, with litigation departments substantially smaller than many of the firms they litigated against, were hailed for representing both defendants and plaintiffs in some of the largest, most complex fights at trial courts, intermediate appellate courts and the US Supreme Court, and leveraging their deep legal talent to achieve remarkable wins for their clients.
In the past year, Kaye Scholer’s victories included the blockbuster Federal Circuit win where the firm successfully represented Acorda Therapeutics in a decision regarding personal jurisdiction in abbreviated new drug applications, as well as a Seventh Circuit victory for Vintage Pharmaceuticals LLC dismissing a generic prescription product liability case on preemption grounds—the first time the court has considered the extent to which product liability claims against generic-prescription-drug manufacturers are preempted by federal law since the US Supreme Court's decisions in Pliva Inc. v. Mensing and Mutual Pharmaceutical Co. Inc. v. Bartlett. Additionally, Kaye Scholer won a unanimous defense verdict on behalf of Philip Morris after a three-week trial when an eight-person jury found that Philip Morris cigarettes did not cause a plaintiff’s lung cancer.
“For each of our clients, we offer a one-stop shop to handle all the related elements of cases that now more than ever involve different and parallel civil, criminal and government investigations,” explained Kaye Scholer managing partner, Michael Solow. “Most importantly, we put our clients’ needs first and recognize the great responsibility we have in our role as their valued advisor."
Law360’s Litigation Powerhouse firms were chosen by examining the size of the firm’s litigation teams, as well as the outstanding victories those teams achieved between March 1, 2015 and March 1, 2016. Law360 editors also weighed in on the nature of the victories that firms achieved for clients on trial, on appeal or in pretrial dismissals over the past year, and assessed each firm’s new matters, selecting firms that regularly leveraged a deep bench into notable wins.
Also of Interest
- And Now A Word From The Panel: 3 Alternatives To MDLs September 28, 2016 • Articles
- Kaye Scholer Represents Investors in Volkswagen Diesel Emissions Litigation September 28, 2016 • Client Successes
- NLJ Names Shores as Antitrust Trailblazer September 27, 2016 • Recognitions
- Shape of Things to Come: Protecting Product Configuration and Packaging Design September 26, 2016 • Articles
- On the Road to a Safe and Secure Internet of Things: What Companies Should Do September 19, 2016 • Articles
- Druckenbrodt Quoted in Bloomberg on Volkswagen Dieselgate September 14, 2016 • Media Mentions
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes